CL2004000705A1 - Sales cristalinas de compuestos derivados de n-formil-hidroxilamina, inhibidores de peptidil desformilasa (pdf); procedimiento de preparacion de las sales; composicion farmaceutica que las contiene; y su uso para tratar y/o prevenir un trastorno infe - Google Patents

Sales cristalinas de compuestos derivados de n-formil-hidroxilamina, inhibidores de peptidil desformilasa (pdf); procedimiento de preparacion de las sales; composicion farmaceutica que las contiene; y su uso para tratar y/o prevenir un trastorno infe

Info

Publication number
CL2004000705A1
CL2004000705A1 CL200400705A CL2004000705A CL2004000705A1 CL 2004000705 A1 CL2004000705 A1 CL 2004000705A1 CL 200400705 A CL200400705 A CL 200400705A CL 2004000705 A CL2004000705 A CL 2004000705A CL 2004000705 A1 CL2004000705 A1 CL 2004000705A1
Authority
CL
Chile
Prior art keywords
hydroxylamine
desformilasa
peptidil
formil
infe
Prior art date
Application number
CL200400705A
Other languages
English (en)
Inventor
Joel Liu Hui Bajwa Jogin Slade
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33131903&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2004000705(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of CL2004000705A1 publication Critical patent/CL2004000705A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

SE DESCRIBEN CIERTOS COMPUESTOS DE N-FORFMIL HIDROXILAMINA, TALES COMO N-(1-OXO-2-ALQUIL-3-(N-HIDROXIFORMAMIDO)-PROPIL)-(CARBONIL-AMINO-ARIL O HETEROARIL)-AZACICLO4-7ALCANOS O TRIAZACICLO4-7ALCANOS O IMIDAZACICLO4-7ALCANOS, QUE SON UTILES EN EL TRATAMIENTO DE INFECCIONES BACTERIANAS. TAMBIEN SE DESCRIBEN SALES CRISTALINAS DE DICHOS COMPUESTOS.
CL200400705A 2003-04-02 2004-04-01 Sales cristalinas de compuestos derivados de n-formil-hidroxilamina, inhibidores de peptidil desformilasa (pdf); procedimiento de preparacion de las sales; composicion farmaceutica que las contiene; y su uso para tratar y/o prevenir un trastorno infe CL2004000705A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45972603P 2003-04-02 2003-04-02

Publications (1)

Publication Number Publication Date
CL2004000705A1 true CL2004000705A1 (es) 2005-01-14

Family

ID=33131903

Family Applications (1)

Application Number Title Priority Date Filing Date
CL200400705A CL2004000705A1 (es) 2003-04-02 2004-04-01 Sales cristalinas de compuestos derivados de n-formil-hidroxilamina, inhibidores de peptidil desformilasa (pdf); procedimiento de preparacion de las sales; composicion farmaceutica que las contiene; y su uso para tratar y/o prevenir un trastorno infe

Country Status (25)

Country Link
US (1) US20070135353A1 (es)
EP (1) EP1613305A1 (es)
JP (1) JP2006522054A (es)
KR (1) KR20060002915A (es)
CN (1) CN1764450A (es)
AR (1) AR043804A1 (es)
AU (1) AU2004226815B2 (es)
BR (1) BRPI0409009A (es)
CA (1) CA2520682A1 (es)
CL (1) CL2004000705A1 (es)
CO (1) CO5630028A2 (es)
EC (1) ECSP056043A (es)
IS (1) IS8093A (es)
MA (1) MA27763A1 (es)
MX (1) MXPA05010610A (es)
MY (1) MY136854A (es)
NO (1) NO20055097L (es)
NZ (1) NZ542432A (es)
PE (1) PE20050392A1 (es)
RU (1) RU2005133660A (es)
SG (1) SG166681A1 (es)
TN (1) TNSN05248A1 (es)
TW (1) TW200427458A (es)
WO (1) WO2004087133A1 (es)
ZA (1) ZA200507179B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2283589T3 (es) 2001-06-15 2007-11-01 Vicuron Pharmaceuticals, Inc. Compuestos biciclicos de pirrolidina.
US7589216B2 (en) 2002-09-19 2009-09-15 Novartis Ag Process for preparing N-hydroxyformamido-propyl pyrrolidin compounds and intermediates
JP2006519786A (ja) 2003-02-21 2006-08-31 ノバルティス アクチエンゲゼルシャフト Ｎ−ホルミルヒドロキシルアミン化合物を得るための中間体作成に関する化学的方法
GT200600196A (es) * 2005-05-23 2007-01-15 Compuestos n-formil de hidroxilamina
US10738028B2 (en) 2016-05-11 2020-08-11 Rudong Ruien Pharmaceutical Technology Co. Ltd Spiro three-membered ring, spiro five-membered ring peptide deformylase inhibitor and use thereof in antibacteria and anti-tumor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3282986A (en) * 1960-10-06 1966-11-01 Merck & Co Inc N-acylated hydroxamic acids and derivatives thereof
GB2349884A (en) * 1998-02-07 2000-11-15 British Biotech Pharm Antibacterial agents
AR036053A1 (es) * 2001-06-15 2004-08-04 Versicor Inc Compuestos de n-formil-hidroxilamina, un proceso para su preparacion y composiciones farmaceuticas

Also Published As

Publication number Publication date
SG166681A1 (en) 2010-12-29
TW200427458A (en) 2004-12-16
NO20055097D0 (no) 2005-11-01
JP2006522054A (ja) 2006-09-28
EP1613305A1 (en) 2006-01-11
TNSN05248A1 (en) 2007-06-11
AU2004226815A1 (en) 2004-10-14
US20070135353A1 (en) 2007-06-14
PE20050392A1 (es) 2005-06-19
AR043804A1 (es) 2005-08-10
MA27763A1 (fr) 2006-02-01
NO20055097L (no) 2005-12-22
MY136854A (en) 2008-11-28
NZ542432A (en) 2009-04-30
KR20060002915A (ko) 2006-01-09
ZA200507179B (en) 2006-04-26
WO2004087133A1 (en) 2004-10-14
AU2004226815B2 (en) 2007-07-19
ECSP056043A (es) 2006-01-27
BRPI0409009A (pt) 2006-03-28
MXPA05010610A (es) 2005-11-23
IS8093A (is) 2005-10-27
CA2520682A1 (en) 2004-10-14
CN1764450A (zh) 2006-04-26
RU2005133660A (ru) 2006-06-10
CO5630028A2 (es) 2006-04-28

Similar Documents

Publication Publication Date Title
ECSP099525A (es) Inhibidores de mek
CL2019000815A1 (es) Compuestos arilo o heteroarilo sustituidos con amino como inhibidores de ehmt1 y ehmt2. (divisional solicitud 201802928).
EA200901617A1 (ru) Борсодержащие молекулы небольшого размера
CL2004002050A1 (es) Compuestos derivados de piridinonas sustituidas; su uso en el tratamiento de afecciones causadas o exacerbadas por actividad p38 map kinasa y/o tnf no regulada, tales como inflamaciones, tumores, sida y otros.
BRPI0617165A2 (pt) Compostos inibidores mek, composições farmacêuticas que os contem e métodos de uso dos mesmos
BR112015032736A2 (pt) inibidores de bromodomínio cristalino
UY31860A (es) Piridinas de tiazolo como inhibidoras de la adn girasa
UY31073A1 (es) Inhibidores de la proteína activadora de la 5-lipoxigenasa (flap)
EA201070247A1 (ru) Ингибиторы протеасом
UY31673A1 (es) "derivados heterocíclicos de urea y métodos de uso de los mismos-211"
UY30759A1 (es) Compuestos quimicos
HN2009001112A (es) Inhibidores de la actividad de la akt
EA200801291A1 (ru) Карбониламинопирролопиразолы в качестве эффективных ингибиторов киназ
CY1109916T1 (el) Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις
CO6382173A2 (es) Moduladores de la lta4h de fenilo y piridilo
CL2009000316A1 (es) Compuestos derivados de urea de benzomorfanos y sus sales, inhibidores de la enzima 11-beta-hidroxiesteroide deshidrogenasa; procedimiento de preparacion; composicion farmaceutica; y uso para el tratamiento o prevencion de trastornos metabolicos.
EA200701771A1 (ru) Низкомолекулярные ингибиторы mdm2 и их применение
ECSP078013A (es) Inhibidores heterocíclicos de mek y métodos de uso de ellos
EA201490922A1 (ru) ПРОИЗВОДНЫЕ ГИДАНТОИНА, ПОЛЕЗНЫЕ В КАЧЕСТВЕ ИНГИБИТОРОВ Kv3-КАНАЛОВ
CL2007002492A1 (es) Compuestos derivados de bi-,tri o policiclos no aromaticos, inhibidores de la enzima 11-beta-hidroxiesteroide deshidrogenasa tipo i; proceso de preparacion de estos; composicion famaceutica que los comprende; uso en el tratamiento de enfermedades tales como la obesidad, diabetes y dislipidemia, entre otras.
ECSP099776A (es) Moduladores de la gamma secretasa
BR112013032711A2 (pt) composições farmacêuticas compreendendo sulbactam e inibidor de beta-lactamase
PA8719401A1 (es) Compuestos de tetrahidropiridotienopirimidina y metodos para su empleo
DK1641803T3 (da) Thienopyrimidinderivater som kaliumkanalinhibitorer
CL2011000147A1 (es) Compuestos derivados de carbamato de alquiltiazol, inhibidores de la enzima faah; composicion farmaceutica que los comprende; procedimiento de preparacion de estos; y sus usos en el tratamiento de dolores agudos o cronicos, vertigo, vomitos, nauseas, epilepsias, entre otras.